Skip to content

    CVS HEALTH Corp

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Trend
    EarningsRevenue
    $91.23B
    $95.43B
    $97.71B
    $94.59B
    $98.92B
    +8.4%
    $102.87B
    +7.8%
    $105.69B
    +8.2%
    $100.43B
    +6.2%
    Strengthening
    Operating Profit
    $3.04B
    $832.00M
    $2.37B
    $3.37B
    $2.38B
    -21.8%
    -$3.21B
    -485.5%
    $2.11B
    -10.8%
    $4.68B
    +38.7%
    Weakening
    Net Profit
    $1.77B
    $87.00M
    $1.64B
    $1.78B
    $1.02B
    -42.3%
    -$3.98B
    -4669.0%
    $2.94B
    +79.0%
    $2.94B
    +65.4%
    Weakening
    EPS
    $1.41
    $0.07
    $1.41
    $0.81
    -42.6%
    $-3.13
    -4571.4%
    $2.31
    +63.8%
    Weakening
    Other Income
    Interest
    $732.00M
    $752.00M
    $758.00M
    $785.00M
    $763.00M
    +4.2%
    $784.00M
    +4.3%
    $787.00M
    +3.8%
    $774.00M
    -1.4%
    Stable
    Depreciation
    Profit before Tax
    $2.34B
    $105.00M
    $2.13B
    $2.62B
    $1.65B
    -29.5%
    -$3.48B
    -3416.2%
    $1.35B
    -36.3%
    $3.94B
    +50.5%
    Weakening
    MarginsOPM
    3.3%
    0.9%
    2.4%
    3.6%
    2.4%
    -27.8%
    -3.1%
    -458.6%
    2.0%
    -17.4%
    4.7%
    +30.5%
    Weakening
    Tax
    24.4%
    32.4%
    23.7%
    31.9%
    38.5%
    +58.1%
    -14.6%
    -145.1%
    -115.9%
    -589.8%
    24.9%
    -21.9%
    Weakening
    ReturnsROIC
    1.6%
    0.1%
    1.4%
    1.6%
    0.9%
    -42.3%
    -3.5%
    -4669.0%
    2.6%
    +79.0%
    2.6%
    +65.4%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$4.06B$5.68B$7.85B$9.41B$12.95B$8.20B$8.59B$8.45B$9.54B
    Short-Term Investments
    Total Current Assets$45.24B$50.30B$56.37B$60.01B$65.63B$67.86B$68.64B$74.71B$74.82B
    Net PP&E$11.35B$32.90B$33.34B$32.02B$30.75B$30.43B$28.94B$28.06B$27.78B
    Goodwill$78.68B$79.75B$79.55B$79.12B$78.15B$91.27B$91.27B$85.48B$85.48B
    Intangibles$36.52B$33.12B$31.14B$29.03B$24.80B$29.23B$27.32B$25.51B$25.07B
    Total Assets$196.46B$222.45B$230.72B$233.00B$228.28B$249.73B$253.22B$253.54B$252.97B
    LiabilitiesTotal Current Liabilities$44.01B$53.30B$62.02B$67.81B$69.42B$79.19B$84.61B$88.69B$86.41B
    Short-Term Debt$1.26B$3.78B$0$0$200.00M$2.12B$0
    Long-Term Debt$71.44B$64.70B
    Long-Term Leases$0$18.93B$18.76B$18.18B$16.80B$16.03B$14.90B$13.64B$13.33B
    Total Liabilities$137.91B$158.28B$161.01B$157.62B$156.51B$173.09B$177.49B$178.16B$175.34B
    EquityCommon Stock & APIC$45.44B$45.97B$46.51B$47.38B$48.19B$48.99B$49.66B$50.40B$50.68B
    Retained Earnings$40.91B$45.11B$49.64B$54.91B$56.40B$61.60B$62.84B$61.20B$63.28B
    Total Equity$58.23B$63.86B$69.39B$75.08B$71.47B$76.46B$75.56B$75.21B$77.46B
    HighlightsNet Cash / (Debt)-$68.65B-$62.80B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$8.87B$12.85B$15.87B$18.27B$16.18B$13.43B$9.11B$10.64B$10.33B
    Cash from Investing-$43.28B-$3.34B-$5.53B-$5.26B-$5.05B-$20.89B-$7.61B-$5.87B-$5.98B
    Cash from Financing$36.82B-$7.65B-$7.70B-$11.36B-$10.52B$2.68B-$1.14B-$4.94B-$4.93B
    SummaryCapital Expenditure-$2.04B-$2.46B-$2.44B-$2.52B-$2.73B-$3.03B-$2.78B-$2.83B-$2.94B
    Free Cash Flow$6.83B$10.39B$13.43B$15.74B$13.45B$10.39B$6.33B$7.81B$7.39B
    FCF Margin3.5%4.0%5.0%5.4%4.2%2.9%1.7%1.9%1.8%